Furthermore, PTPN22 gene polymorphisms may be involved in the formation of citrullinated peptide-specific CD4+ T cells and therefore be a risk factor for ACPA+ RA [42]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.